PBI-4547
- Generic Name
- PBI-4547
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Liminal BioSciences Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04068259
- Locations
- 🇨🇦
Syneos Health, Québec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath